vitherapharma.com
ViThera-HomeViThera Pharmaceuticals –
http://www.vitherapharma.com/
ViThera Pharmaceuticals –
http://www.vitherapharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
0.6 seconds
16x16
DOMAIN PRIVACY SERVICE FBO REGISTRANT
1958 S●●●●●●0 EAST
PR●●VO , UTAH, 84606
UNITED STATES
View this contact
DOMAIN PRIVACY SERVICE FBO REGISTRANT
1958 S●●●●●●0 EAST
PR●●VO , UTAH, 84606
UNITED STATES
View this contact
DOMAIN PRIVACY SERVICE FBO REGISTRANT
1958 S●●●●●●0 EAST
PR●●VO , UTAH, 84606
UNITED STATES
View this contact
BUY YOUR DOMAIN
14
YEARS
6
MONTHS
15
DAYS
FASTDOMAIN, INC.
WHOIS : whois.fastdomain.com
REFERRED : http://www.fastdomain.com
PAGES IN
THIS WEBSITE
12
SSL
EXTERNAL LINKS
2
SITE IP
162.144.16.49
LOAD TIME
0.625 sec
SCORE
6.2
ViThera-Home | vitherapharma.com Reviews
https://vitherapharma.com
ViThera Pharmaceuticals –
vitherapharma.com
ViThera-News
http://www.vitherapharma.com/investors.html
ViThera’s innovative EnLact technology delivers drugs directly to diseased epithelial sites (intestinal wall, vaginal wall, skin) so the drugs are available in high local concentrations. ViThera’s probiotic bacteria are evolved to associate closely with epithelial cells. ViThera enhances these probiotics to produce and release drugs right against their target tissue where they are needed. For information on investment opportunities. Web development by Anthony Baldor.
ViThera-People
http://www.vitherapharma.com/people.html
Thomas E. Spike. President and Chief Executive Officer). Johannes Fruehauf (MD PhD). Founder and Chief Scientific Officer). RNA interference, the only RNAi therapeutic targeting the gastrointestinal tract. Dr. Fruehauf is the author of over 20 peer reviewed publications and is a named inventor on 14 patents related to RNA interference and bacterial therapeutics. (top). F Stephen Laroux (PhD). Consultant, Inflammatory Diseases). Web development by Anthony Baldor.
ViThera-Careers
http://www.vitherapharma.com/careers.html
ViThera Pharmaceuticals, Inc. is developing new biopharmaceutical products based on a better understanding of the crosstalk between the microbiome and the body. The ViThera team is comprised of highly motivated and committed scientists and business professionals. Our people make the biggest impact in delivering innovational therapeutics. If you are interested in opportunities at ViThera Pharmaceuticals, please forward your CV or resume to info@vitherapharma.com. Web development by Anthony Baldor.
ViThera-Publications
http://www.vitherapharma.com/publications.html
Motta, et al. Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroentreology 2011 Apr;140(4):1272-82. Buttaro C and Fruehauf JH. Engineered E. coli as Vehicles for Targeted Therapeutics. Curr Gene Ther. 2010 Feb;10(1):27-33. Transkingdom RNA interference (tkRNAi as a new delivery tool for therapeutic RNA. Expert Opin Biol Ther. 2009 Dec;9(12):1533-42. Kruhn A et al. Cell Cycle. 2009 Oct 15;8(20):3349-3354. Chen X et al. Nguyen T and Fruehauf JH.
ViThera-Services
http://www.vitherapharma.com/services.html
ViThera Pharmaceuticals sister company, Cambridge Biolabs. Our labs are organized to execute fast, early stage support to the biotechnology and pharmaceutical industry. Use our. Capacity for comprehensive project-based solutions. CBL handles projects as simple as running an overflow of western blots and as thorough as lead identification/optimization and pipeline development. Come see our labs today. Currently available services include:. Experts in RNAi-based drug development. Quantitative real time PCR.
TOTAL PAGES IN THIS WEBSITE
12
Clients | Cambridge Biolabs
http://www.cambridgebiolabs.com/client
Early stage support for the start-up biotech industry. May 10, 2012. 1087systems is developing a platform for high-throughput label-free cytometry based on newly-available optical components. 1087systems is founded by serial entrepreneur Matthias Wagner and uses Cambridge Biolabs for their biology laboratory needs. May 1, 2012. March 21, 2012. December 30, 2011. Advirna develops innovative solutions for efficient delivery of polynucleotides in vivo. Advirna’s proprietary RNAi platform based on self-d...
Web Development | Anthony Edward Baldor
http://www.anthonybaldor.com/web-development
This is what I do to relax when it is too dark outside to ride a bike or sail a boat. Healthspan: State of the Industry. Amfernee Baller Internet Detritus. A website is a tool for communication. It is an essay. It should be simple and clear. UC Berkeley Bplan Competition. BioInnovation is a boutique venture capital firm with a team of high-profile, high-net worth individuals who have decades of experience building and selling biotechnology companies. BioInnovation invests in promising startup life sc...
TOTAL LINKS TO THIS WEBSITE
2
Vidéographe
Http:/ www.interactivewebs.com. Search in catalog :. 1533 title(s) found. Showing page 1 of 192. Some phenomena of the skin reveal activity of the body which is independent of the will, a non-conscious consciousness which is itself the essence of life. Lettres vidéo) (Preview only). To Live at Last. Borrowing images from Alfred Hitchcock's. Lefave revisits one of the most famous murder scenes in film history. In this case however, the search is for the absent female body. Is the female gaze dead?
Vither
Vither Hyperthermia develops advanced Whole Body Hyperthermia Devices for clinical therapy. The device increases the body core temperature by venous perfusion to approximately 42,5C for two hours in support of an oncological treatment. Clinical studies are carried out by UMC St Radboud in the Netherlands. Due to confidentiality reasons we can not provide more information at this time. Tel: 31 508 508 960.
VITHERA Vital- und Therapiezentrum
Tel 43 (0) 7712 356 73. Wellness & mehr. Wellness & mehr. Wir sind eine wahltherapeutische Praxisgemeinschaft in Schärding (A-Tarif) mit den Schwerpunkten Physiotherapie. Sie wurde 2007 gegründet und das jetzt bestehende Team setzt sich aus. Spezialisten der Fachbereiche Orthopädie, Chirurgie, Neurologie, Schmerztherapie, Sport- und Atemphysiotherapie. Desweiteren haben Sie die Möglichkeit, neben Anwendungen aus der. Reichhaltigen Massage- und Wellnessangebote. Zu nutzen, um etwas.
vithera
Praxis für Vital -Therapie und Prävention. Für eine richtige Darstellung der Seite muß Java aktiviert sein!
Cambridge Biolabs
Early stage support for the start-up biotech industry. Our clients have raised over $300M since 2009! CBL manages over a dozen of our cell lines for this project. Enabling my invention in the BioCloud saved me from sharing IP with the university. On to the next level our own lab! Thank you, CBL! Johannes and his team have added tremendous value to our strategy sessions. This lab has everything I need for daily experimentation and CBL has access to any specialized equipment I need.
ViThera-Home
ViThera Pharmaceuticals is an early stage biotech company located in the life-science cluster at One Kendall Square in Cambridge, MA. Our scientists harness the synthetic potential of bacteria to produce therapeutic molecules within the body to develop a revolutionary new treatment for Inflammatory Bowel Disease. Our close collaboration with prominent academic researchers developing the EnLact in the United States and in Europe concept puts us at the cutting edge of biologic therapy. Strong proof of ...
Therapy Association and Disabilities Advocates. - T.A.D.A
Welcome to the Therapy Association and Disabilities Advocates (TADA) Website. Therapy Association and Disabilities Advocates. Formerly Known As the VIRGIN ISLANDS THERAPY ASSOCIATION (VITA), the. Therapy Association and Disabilities Advocates (TADA). Is made up of volunteering Occupational therapists, Physical therapists, Speech therapists, and associated allied professionals. The mission statement of the Therapy Association and Disabilities Advocates or 'TADA'. Contact us for info. TADA Events Coming Up.
Vitheras
Protegidos de las masas de aire húmedo de la costa por inmensas barreras montañosas, los viñedos asturianos se sitúan en las laderas soleadas de los profundos valles de Cangas del Narcea. Se trata de una viticultura heroica, difícil, en fuerte pendiente, pero cuyas variedades presentan un alto nivel de adaptación a las singulares condiciones de suelo y clima de estos valles, produciendo vinos únicos y perfectamente reconocibles. La Guerra, la enfermedad y el olvido. La recuperación y el retorno de la vid.
VIT HERDE | VIT HERDEHUND / BERGER BLANC SUISSE / WHITE SWISS SHEPHERD
VIT HERDEHUND / BERGER BLANC SUISSE / WHITE SWISS SHEPHERD. Den 4 och 5 maj var Robin och jag på två internationella utställningar i Roskilde. På lördagen, i solsken och blåst, blev Robin bästa hane och fick därmed det danska cert han behövde för danskt utställningschampionat. Kitty Sjong vad det som dömde och hon placerade Robin som BIM efter en finsk tik. Så helgens skörd blev: 2*excellent, 2*1:a chkk, 2*ck, 1:a bhkl, 2:a bhkl, 2*cacib, cert, BIM DK UCH. Mission completed ;). Foto: Nina Storm Jensen.
vitherdehund -
Ny blogg / hemsida! Utrymmet på denna blogg börjar ta slut så därför har jag fixat en ny blogg / hemsida så att jag inte måste radera en massa gamla bilder. Ni hittar den nya här: http:/ www.aktivhundsport.com/akira-aiko/. 2009-03-27 @ 21:06:58 Permalink. Snart vår och nytt halsband. Vi var till Vasa i fredags för att handla lite onödiga grejer och dessutom var jag och pratade med min handledare om slutarbetet. Här är ett foto från gårdagens promenad på Kiren med hennes nya halsband:. Här är också en gam...
BARVESTADS KENNEL FCI 2005 - 2015 10 years of breeding White Swiss Shepherd
BARVESTADS KENNEL FCI 2005 - 2015. 10 years of breeding White Swiss Shepherd. Vit herdehund, Berger Blanc Suisse, White Swiss Shepherd Dog. KORAD, NOUCH, FIUCH, SEUCH, SE V-11 Barvestads Cheops of Giza. Svensk utställningschampion 20/4 - 2008. Svensk Vinnare 21/8 - 2011. KORAD 17/5 - 2012. Best in Show Rasspecialen 2012. VHK Domarens specialpris - Bästa Huvud och Uttryck 2012. VHK Domarens specialpris - Bästa Rörelser 2014. Finsk utställningschampion 30/9 - 2012. Norsk utställningschampion 13/10 - 2012.
